Healthcare provider profile · identity verified

Jonathan M Kolodny, M.D.

Internal Medicine · NORWOOD, MA · NPI 1649277674

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	843	229
Hydrochlorothiazide	Hydrochlorothiazide	553	161
Levothyroxine Sodium	Levothyroxine Sodium	483	130
Metoprolol Succinate	Metoprolol Succinate	469	126
Lisinopril	Lisinopril	444	120
Lorazepam	Lorazepam	355	83
Amlodipine Besylate	Amlodipine Besylate	335	94
Omeprazole	Omeprazole	322	96
Losartan Potassium	Losartan Potassium	291	82
Eliquis	Apixaban	276	58
Metformin Hcl	Metformin Hcl	251	77
Simvastatin	Simvastatin	251	72
Furosemide	Furosemide	211	52
Rosuvastatin Calcium	Rosuvastatin Calcium	211	60
Gabapentin	Gabapentin	196	45
Synthroid	Levothyroxine Sodium	156	44
Trulicity	Dulaglutide	154	33
Ozempic	Semaglutide	146	24
Pantoprazole Sodium	Pantoprazole Sodium	144	42
Pravastatin Sodium	Pravastatin Sodium	143	40
Potassium Chloride	Potassium Chloride	141	42
Trazodone Hcl	Trazodone Hcl	135	37
Atenolol	Atenolol	128	33
Metoprolol Tartrate	Metoprolol Tartrate	125	37
Famotidine	Famotidine	124	36
Sertraline Hcl	Sertraline Hcl	120	29
Prednisone	Prednisone	118	45
Tamsulosin Hcl	Tamsulosin Hcl	113	35
Jardiance	Empagliflozin	109	25
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	104	33
Farxiga	Dapagliflozin Propanediol	103	22
Albuterol Sulfate Hfa	Albuterol Sulfate	100	38
Citalopram Hbr	Citalopram Hydrobromide	96	24
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	88	21
Alprazolam	Alprazolam	87	16
Tramadol Hcl	Tramadol Hcl	85	21
Allopurinol	Allopurinol	83	27
Warfarin Sodium	Warfarin Sodium	79	20
Amitriptyline Hcl	Amitriptyline Hcl	72	20
Colchicine	Colchicine	72	17
Mirtazapine	Mirtazapine	72	13
Escitalopram Oxalate	Escitalopram Oxalate	69	23
Alendronate Sodium	Alendronate Sodium	67	23
Ezetimibe	Ezetimibe	67	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	24
Mounjaro	Tirzepatide	61	11
Zolpidem Tartrate	Zolpidem Tartrate	60	15
Clonazepam	Clonazepam	59	11
Glimepiride	Glimepiride	57	18
Celecoxib	Celecoxib	54	11
Finasteride	Finasteride	53	13
Nifedipine Er	Nifedipine	50	11
Testosterone	Testosterone	50	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	17
Montelukast Sodium	Montelukast Sodium	47	14
Olmesartan Medoxomil	Olmesartan Medoxomil	47	11
Oxybutynin Chloride Er	Oxybutynin Chloride	46	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	45	15
Hydralazine Hcl	Hydralazine Hcl	45	13
Donepezil Hcl	Donepezil Hcl	43	11
Irbesartan	Irbesartan	43	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	42	12
Ibuprofen	Ibuprofen	42	14
Paroxetine Hcl	Paroxetine Hcl	42	11
Oxycodone Hcl	Oxycodone Hcl	41	suppressed
Carvedilol	Carvedilol	40	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	40	15
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	38	suppressed
Humalog Kwikpen U-100	Insulin Lispro	38	13
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	38	14
Labetalol Hcl	Labetalol Hcl	36	suppressed
Terazosin Hcl	Terazosin Hcl	36	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Indapamide	Indapamide	34	suppressed
Penicillin V Potassium	Penicillin V Potassium	34	suppressed
Propranolol Hcl	Propranolol Hcl	33	13
Cefpodoxime Proxetil	Cefpodoxime Proxetil	32	25
Glipizide	Glipizide	32	suppressed
Novolog Flexpen	Insulin Aspart	32	11
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Azithromycin	Azithromycin	30	28
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	30	suppressed
Diazepam	Diazepam	30	suppressed
Lovastatin	Lovastatin	30	suppressed
Valsartan	Valsartan	30	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	29	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Metformin Hcl Er	Metformin Hcl	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	12
Bupropion Xl	Bupropion Hcl	27	suppressed
Amiloride Hcl	Amiloride Hcl	26	suppressed
Bydureon Bcise	Exenatide Microspheres	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Nystatin	Nystatin	26	14
Methylprednisolone	Methylprednisolone	25	16
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Tresiba Flextouch U-100	Insulin Degludec	24	suppressed
Carisoprodol	Carisoprodol	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Lactulose	Lactulose	22	suppressed
Acebutolol Hcl	Acebutolol Hcl	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Colestipol Hcl	Colestipol Hcl	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Sildenafil Citrate	Sildenafil Citrate	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Temazepam	Temazepam	19	suppressed
Tiotropium Bromide	Tiotropium Bromide	19	suppressed
Fluticasone Propionate	Fluticasone Propionate	18	suppressed
Topiramate	Topiramate	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Fluconazole	Fluconazole	17	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Admelog Solostar	Insulin Lispro	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Premarin	Estrogens, Conjugated	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	12
Meclizine Hcl	Meclizine Hcl	15	suppressed
Risperidone	Risperidone	15	suppressed
Fentanyl	Fentanyl	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Amiloride-Hydrochlorothiazide	Amiloride/Hydrochlorothiazide	13	suppressed
Atrovent Hfa	Ipratropium Bromide	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Primidone	Primidone	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Triazolam	Triazolam	12	suppressed
Digoxin	Digoxin	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error